Related Tags >> FDA Phase III Phase II Experimental Drugs

Drug Trials News

Most Popular Drug Trials Story

Who's next on the biotech buyout hit list?

October 16, 2007 — 5:59am ET

Now that Biogen Idec is in play, the analysts are on the lookout for the next big acquisition target. Bear Stearns' Mark Read more...

Drug Trials Press Releases

Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Great

Latest Headlines

Cancer researchers testing radical change in drug trials
October 4, 2010
PTC124 proves promising in cystic fibrosis trial
August 21, 2008
Acadia shares plunge on mid-stage trial failure
June 16, 2008
Symphogen inks $330M collaboration pact with Genentech
June 11, 2008
Novo Nordisk discontinues Phase III on disappointing results
June 11, 2008
BioSante Pharma exploring its strategic alternatives
June 10, 2008
Vertex shares rise on positive data for telaprevir
June 9, 2008
Inspire Pharma shares soar 75% on CF data
June 6, 2008
IRX Therapeutics raises $25M Series A
June 3, 2008
Amgen's D-mab beats Fosamax in trial
May 28, 2008
ALSO NOTED: FDA, Medicare team up on drug surveillance; Early stage prostate vaccine shows promise; and much more...
May 23, 2008
Myriad Genetics pencils in $350M deal for Flurizan
May 22, 2008
Progenics, Wyeth drug fails late-stage trial
May 22, 2008
A deluge of pre-ASCO data hits the market
May 16, 2008
Antisoma buys Xanthus for $52M
May 16, 2008
NicOx shares plunge on Pfizer trial failure
May 6, 2008
Rituxan fails (again) in late-stage lupus trial
April 29, 2008
Nuon gets $27M to fund a mid-stage trial
April 28, 2008
Drug work completed, Theravance cuts 40% of staff
April 23, 2008
Scarring data update boosts battered Renovo shares
April 18, 2008

Paid Research Reports

More Research Reports >>